Smith Christopher M
Insider CIK 1436707 · NEO Chief Executive Officer · UBI Director · PACB Director · AKUS Director · OCDX Chairman and CEO, Director · QDEL Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| PACB PACIFIC BIOSCIENCES OF CAL | A Award deriv | 2026-06-03 | 2026-06-04 | 223,492 | — | $0 | 223,492 | SEC↗ |
| PACB PACIFIC BIOSCIENCES OF CAL | A Award deriv | 2025-06-04 | 2025-06-06 | 32,500 | — | $0 | 32,500 | SEC↗ |
| NEO NEOGENOMICS INC | M Exercise deriv | 2025-02-23 | 2025-02-25 | 57,413 | — | $0 | 114,826 | SEC↗ |
| NEO NEOGENOMICS INC | F Tax w/h | 2025-02-23 | 2025-02-25 | 14,067 | — | $0 | 641,585 | SEC↗ |
| NEO NEOGENOMICS INC | M Exercise | 2025-02-23 | 2025-02-25 | 57,413 | — | $0 | 655,652 | SEC↗ |
| PACB PACIFIC BIOSCIENCES OF CAL | A Award deriv | 2025-01-30 | 2025-02-03 | 72,901 | — | $0 | 72,901 | SEC↗ |
| PACB PACIFIC BIOSCIENCES OF CAL | A Award | 2025-01-30 | 2025-02-03 | 54,099 | — | $0 | 54,099 | SEC↗ |
| NEO NEOGENOMICS INC | F Tax w/h | 2024-08-15 | 2024-08-19 | 33,130 | — | $0 | 646,302 | SEC↗ |
| NEO NEOGENOMICS INC | M Exercise deriv | 2024-05-11 | 2024-12-04 | 48,063 | — | $0 | 96,127 | SEC↗ |
| NEO NEOGENOMICS INC | F Tax w/h | 2024-05-11 | 2024-12-04 | 18,913 | $14.86 | $281.0K | 631,369 | SEC↗ |
| NEO NEOGENOMICS INC | M Exercise | 2024-05-11 | 2024-12-04 | 48,063 | — | $0 | 650,282 | SEC↗ |
| NEO NEOGENOMICS INC | M Exercise deriv | 2024-05-11 | 2024-05-14 | 48,063 | — | $0 | 96,127 | SEC↗ |
| NEO NEOGENOMICS INC | F Tax w/h | 2024-05-11 | 2024-05-14 | 18,913 | $14.86 | $281.0K | 631,369 | SEC↗ |
| NEO NEOGENOMICS INC | M Exercise | 2024-05-11 | 2024-05-14 | 48,063 | — | $0 | 650,282 | SEC↗ |
| NEO NEOGENOMICS INC | M Exercise | 2024-05-11 | 2024-05-14 | 48,063 | — | $0 | 679,432 | SEC↗ |
| NEO NEOGENOMICS INC | A Award deriv | 2024-02-23 | 2024-02-27 | 287,940 | — | $0 | 287,940 | SEC↗ |
| NEO NEOGENOMICS INC | A Award deriv | 2024-02-23 | 2024-02-27 | 172,239 | — | $0 | 172,239 | SEC↗ |
| NEO NEOGENOMICS INC | A Award deriv | 2024-02-23 | 2024-02-27 | 172,240 | — | $0 | 172,240 | SEC↗ |
| QDEL QuidelOrtho Corp | M Exercise deriv | 2023-06-06 | 2023-06-08 | 2,248 | — | $0 | 0 | SEC↗ |
| QDEL QuidelOrtho Corp | A Award | 2023-06-06 | 2023-06-08 | 2,248 | — | $0 | 2,249 | SEC↗ |
| QDEL QuidelOrtho Corp | F Tax w/h | 2023-05-27 | 2023-05-31 | 1,225 | $85.54 | $104.8K | 33,329 | SEC↗ |
| QDEL QuidelOrtho Corp | A Award deriv | 2023-05-24 | 2023-05-25 | 402 | — | $0 | 402 | SEC↗ |
| QDEL QuidelOrtho Corp | A Award deriv | 2023-05-24 | 2023-05-25 | 80 | — | $0 | 80 | SEC↗ |
| QDEL QuidelOrtho Corp | A Award deriv | 2023-05-24 | 2023-05-25 | 2,416 | — | $0 | 2,416 | SEC↗ |
| NEO NEOGENOMICS INC | A Award deriv | 2023-05-11 | 2023-05-15 | 269,841 | — | $0 | 269,841 | SEC↗ |
| NEO NEOGENOMICS INC | A Award deriv | 2023-05-11 | 2023-05-15 | 144,190 | — | $0 | 144,190 | SEC↗ |
| NEO NEOGENOMICS INC | A Award deriv | 2023-05-11 | 2023-05-15 | 144,190 | — | $0 | 144,190 | SEC↗ |
| NEO NEOGENOMICS INC | A Award deriv | 2022-08-15 | 2022-08-17 | 694,444 | — | $0 | 694,444 | SEC↗ |
| NEO NEOGENOMICS INC | A Award | 2022-08-15 | 2022-08-17 | 336,767 | — | $0 | 336,767 | SEC↗ |
| NEO NEOGENOMICS INC | A Award | 2022-08-15 | 2022-08-17 | 265,452 | — | $0 | 602,219 | SEC↗ |
| AKUS Akouos, Inc. | A Award deriv | 2022-06-23 | 2022-06-27 | 16,000 | — | $0 | 16,000 | SEC↗ |
| QDEL QuidelOrtho Corp | A Award deriv | 2022-06-06 | 2022-06-08 | 2,248 | — | $0 | 2,248 | SEC↗ |
| QDEL QuidelOrtho Corp | A Award | 2022-05-27 | 2022-08-01 | 34,554 | — | $0 | 34,554 | SEC↗ |
| OCDX Ortho Clinical Diagnostics | D To issuer deriv | 2022-05-27 | 2022-06-01 | 1,971,420 | — | $0 | 0 | SEC↗ |
| QDEL QuidelOrtho Corp | A Award deriv | 2022-05-27 | 2022-06-01 | 207,984 | — | $0 | 207,984 | SEC↗ |
| OCDX Ortho Clinical Diagnostics | D To issuer | 2022-05-27 | 2022-06-01 | 367,360 | — | $0 | 0 | SEC↗ |
| QDEL QuidelOrtho Corp | A Award | 2022-05-27 | 2022-06-01 | 34,554 | — | $0 | 34,554 | SEC↗ |
| OCDX Ortho Clinical Diagnostics | M Exercise deriv | 2022-01-03 | 2022-01-05 | 100,000 | — | $0 | 935,710 | SEC↗ |
| OCDX Ortho Clinical Diagnostics | S Sale | 2022-01-03 | 2022-01-05 | 100,000 | $21.10 | $2.11M | 367,360 | SEC↗ |
| OCDX Ortho Clinical Diagnostics | M Exercise | 2022-01-03 | 2022-01-05 | 100,000 | $12.56 | $1.26M | 467,360 | SEC↗ |
| OCDX Ortho Clinical Diagnostics | S Sale | 2021-08-04 | 2021-08-04 | 61,800 | $21.79 | $1.35M | 367,360 | SEC↗ |
| OCDX Ortho Clinical Diagnostics | S Sale | 2021-08-03 | 2021-08-04 | 104,987 | $21.55 | $2.26M | 429,160 | SEC↗ |
| OCDX Ortho Clinical Diagnostics | S Sale | 2021-08-02 | 2021-08-04 | 103,213 | $22.10 | $2.28M | 534,147 | SEC↗ |
| AKUS Akouos, Inc. | A Award deriv | 2021-06-24 | 2021-06-25 | 16,000 | — | $0 | 16,000 | SEC↗ |
| UBI UNIVERSAL BIOSENSORS INC | P Buy | 2014-05-06 | 2014-05-08 | 30,000 | $11249.95 | $337.50M | 30,000 | SEC↗ |